quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:17·633d
SECFiling
Hibbett Inc. logo

SEC Form EFFECT filed by Hibbett Inc.

HIBB· Hibbett Inc.
Consumer Discretionary
Original source

Companies

  • HIBB
    Hibbett Inc.
    Consumer Discretionary

Recent analyst ratings

  • Mar 18UpdateTelsey Advisory Group$74.00
  • Mar 18UpdateMonness Crespi & Hardt$82.00
  • Mar 13UpdateTelsey Advisory Group$82.00
  • Nov 22UpdateTelsey Advisory Group$73.00
  • Nov 22UpdateMonness Crespi & Hardt$72.00
  • Jun 29UpdateB. Riley Securities$37.00

Related

  • 13D/G626d
    Amendment: SEC Form SC 13D/A filed by Hibbett Inc.
  • SEC626d
    SEC Form 15-12G filed by Hibbett Inc.
  • SEC633d
    SEC Form EFFECT filed by Hibbett Inc.
  • SEC633d
    SEC Form EFFECT filed by Hibbett Inc.
  • INSIDER637d
    Director Flur Dorlisa K exercised 7,935 shares at a strike of $87.50, returned $901,775 worth of shares to the company (10,306 units at $87.50) and gifted 4,875 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER637d
    President and CEO Longo Michael E returned $13,567,225 worth of shares to the company (155,054 units at $87.50), exercised 24,933 shares at a strike of $87.50 and was granted 37,400 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER637d
    Director Finley Terrance G returned $282,275 worth of shares to the company (3,226 units at $87.50), closing all direct ownership in the company (SEC Form 4)
  • INSIDER637d
    SVP General Counsel Benck David Mitchell exercised 6,234 shares at a strike of $87.50, was granted 9,349 shares and returned $3,888,588 worth of shares to the company (44,441 units at $87.50), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022